Incidence of arterial cardiovascular events after venous thromboembolism: a systematic review and a meta-analysis

被引:78
作者
Becattini, C. [1 ,2 ]
Vedovati, M. C. [1 ,2 ]
Ageno, W. [3 ]
Dentali, F. [3 ]
Agnelli, G. [1 ,2 ]
机构
[1] Univ Perugia, Div Internal & Cardiovasc Med, I-06129 Perugia, Italy
[2] Univ Perugia, Stroke Unit, I-06129 Perugia, Italy
[3] Univ Insubria, Osped Circolo, Varese, Italy
关键词
acute myocardial infarction; deep venous thrombosis; ischemic stroke; meta-analysis; pulmonary embolism; MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; TERM-FOLLOW-UP; PULMONARY-EMBOLISM; LONG-TERM; RISK-FACTORS; RANDOMIZED-TRIAL; CLINICAL-COURSE; PREVENTION; WARFARIN;
D O I
10.1111/j.1538-7836.2010.03777.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Whether patients with unprovoked venous thromboembolism (VTE) have a higher risk of arterial cardiovascular events than the general population and patients with provoked VTE is a matter of debate. Objective: To perform a systematic review and a meta-analysis aimed at assessing the risk of arterial cardiovascular events in patients with unprovoked VTE as compared with both patients with provoked VTE and controls. Methods: A systematic search was performed. Studies reporting on (i) patients with confirmed VTE, (ii) a follow-up of at least 6 months and (iii) the incidence of arterial cardiovascular events (acute myocardial infarction and ischemic stroke) were included in the systematic review. Those studies reporting separate incidences of cardiovascular events in patients with unprovoked and provoked VTE or patients with unprovoked VTE and controls were included in the incidence rate meta-analysis. Results: Overall, 17 studies were included in the systematic review. The weighted mean incidence of arterial cardiovascular events was 0.46% [95% confidence interval (CI) 0.34-0.59] and 0.35% (95% CI 0.24-0.49) per patient-year in patients with unprovoked and provoked VTE, respectively. Six studies were included in the meta-analysis. The risk of arterial cardiovascular events appeared to be higher in patients with unprovoked VTE than in controls [incidence rate ratio (IRR) 1.87, 95% CI 1.32-2.65] and than in patients with provoked VTE (IRR 1.86, 95% CI 1.19-2.89). Conclusions: Patients with unprovoked VTE have a higher risk of arterial cardiovascular events than patients with provoked VTE over long-term follow-up.
引用
收藏
页码:891 / 897
页数:7
相关论文
共 37 条
[1]   Cardiovascular risk factors and venous thromboembolism - A meta-analysis [J].
Ageno, Walter ;
Becattini, Cecilia ;
Brighton, Timothy ;
Selby, Rita ;
Kamphuisen, Pieter W. .
CIRCULATION, 2008, 117 (01) :93-102
[2]  
[Anonymous], 2001, SYSTEMATIC REV HLTH, DOI DOI 10.1002/9780470693926
[3]   A prospective study on cardiovascular events after acute pulmonary embolism [J].
Becattini, C ;
Agnelli, G ;
Prandoni, P ;
Silingardi, M ;
Salvi, R ;
Taliani, MR ;
Poggio, R ;
Imberti, D ;
Ageno, W ;
Pogliani, E ;
Porro, F ;
Casazza, F .
EUROPEAN HEART JOURNAL, 2005, 26 (01) :77-83
[4]  
Bland JM, 1998, BRIT MED J, V316, P129
[5]   Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism - A retrospective cohort study [J].
Bova, Carlo ;
Marchiori, Antonio ;
Noto, Alfonso ;
Rossi, Vincenza ;
Daniele, Filomena ;
Santoro, Caterina ;
Ricchio, Roberto ;
De Lorenzo, Roberto ;
Umbaca, Rossella ;
Prandoni, Paolo .
THROMBOSIS AND HAEMOSTASIS, 2006, 96 (02) :132-136
[6]   A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome [J].
Crowther, MA ;
Ginsberg, JS ;
Julian, J ;
Denburg, J ;
Hirsh, J ;
Douketis, J ;
Laskin, C ;
Fortin, P ;
Anderson, D ;
Kearon, C ;
Clarke, A ;
Geerts, W ;
Forgie, M ;
Green, D ;
Costantini, L ;
Yacura, W ;
Wilson, S ;
Gent, M ;
Kovacs, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (12) :1133-1138
[7]   Long-term treatment of deep venous thrombosis with a low molecular weight heparin (Tinzaparin): A prospective randomized trial [J].
Daskalopoulos, ME ;
Daskalopoulou, SS ;
Tzortzis, E ;
Sfiridis, P ;
Nikolaou, A ;
Dimitroulis, D ;
Kakissis, I ;
Liapis, CD .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2005, 29 (06) :638-650
[8]   Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis -: A randomized trial [J].
Fiessinger, JN ;
Huisman, MV ;
Davidson, BL ;
Bounameaux, H ;
Francis, CW ;
Eriksson, H ;
Lundström, T ;
Berkowitz, SD ;
Nyström, P ;
Thorsén, M ;
Ginsberg, JS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (06) :681-689
[9]   C-reactive protein and venous thromboembolism A prospective investigation in the ARIC cohort [J].
Folsom, Aaron R. ;
Lutsey, Pamela L. ;
Astor, Brad C. ;
Cushman, Mary .
THROMBOSIS AND HAEMOSTASIS, 2009, 102 (04) :615-619
[10]   A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism [J].
Glynn, Robert J. ;
Danielson, Eleanor ;
Fonseca, Francisco A. H. ;
Genest, Jacques ;
Gotto, Antonio M., Jr. ;
Kastelein, John J. P. ;
Koenig, Wolfgang ;
Libby, Peter ;
Lorenzatti, Alberto J. ;
MacFadyen, Jean G. ;
Nordestgaard, Borge G. ;
Shepherd, James ;
Willerson, James T. ;
Ridker, Paul M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (18) :1851-1861